Frontiers in Nutrition (Jul 2022)

Anthropometric Indicators as Predictors of Mortality in Early Life Among Low Birthweight Indian Infants

  • Tarun Shankar Choudhary,
  • Tarun Shankar Choudhary,
  • Mohan Kumar,
  • Bireshwar Sinha,
  • Bireshwar Sinha,
  • Saijuddin Shaikh,
  • Sarmila Mazumder,
  • Sunita Taneja,
  • Nita Bhandari

DOI
https://doi.org/10.3389/fnut.2022.884207
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundLow birthweight (LBW) babies (<2.5 kg) are at higher risk of mortality and weight for height z score is currently recommended for identifying infants at risk of mortality.ObjectiveTo compare different anthropometric measures at 28-day of age in a cohort of LBW Indian infants for predicting mortality between 28-day and 180-day of age.MethodsWe used data from an individually randomized controlled trial of LBW infants weighing between 1,500 and 2,250 g. Sensitivity, specificity, positive, and negative likelihood ratios, positive and negative predictive values, and area under receiver operating characteristics curves (AUC) were used to estimate the discrimination of mortality risk. The Cox regression was used to estimate hazard ratios and population attributable fraction for each anthropometric indicator. These estimates were calculated for individual as well as combinations of anthropometric indicators at the cut-off of –2 and –3 SD of the WHO 2006 growth standards.ResultsSevere underweight (weight-for-age z-scores [WAZ] < –3) had a sensitivity of 75.0%, specificity of 68.0% with an AUC of 0.72. The risk of death was higher (HR 6.18; 95% CI 4.29–8.90) with a population attributable fraction of 0.63 (95% CI 0.52–0.72) for infants severely underweight at 28-day of age. Combination of different anthropometric measures did not perform better than individual measures.ConclusionSevere underweight (WAZ < –3) better discriminated deaths among LBW infants < 6 months of age. It can be considered for diagnosis of nutritionally at-risk infants in this age group.Clinical Trial Registration[ClinicalTrials.gov], identifier [NCT02653534].

Keywords